Abstract: The present disclosure relates to a plurality of host materials, organic electroluminescent compounds, and organic electroluminescent devices comprising the same. By comprising specific combinations of compounds according to the present disclosure as the plurality of host materials or by comprising a compound according to the present disclosure, it is possible to provide organic electroluminescent devices having improved lifespan characteristics compared to conventional organic electroluminescent devices.

Abstract: The present disclosure relates to an organic electroluminescent compound, a plurality of host materials, and an organic electroluminescent device comprising the same. By comprising the compound according to the present disclosure or by comprising a specific combination of compounds according to the present disclosure as a plurality of host materials, it is possible to produce an organic electroluminescent device having improved driving voltage, luminous efficiency, and/or lifetime properties compared to the conventional organic electroluminescent devices.

Abstract: The present disclosure relates to a plurality of host materials, an organic electroluminescent compound, and an organic electroluminescent device comprising the same. An organic electroluminescent device having improved driving voltage, luminous efficiency, and/or lifespan properties compared to a conventional organic electroluminescent device can be provided by including the specific combination of compounds according to the present disclosure as a plurality of host materials or by including the compound according to the present disclosure.

Abstract: An apparatus of tilting a seat cushion of a vehicle, includes a tilting motor, a pinion gear, a sector gear, and a tilting link which perform the tilting operation of the seat cushion and exert a binding force in a tilted state of the seat cushion and are provided to be connected to both of one side and the other side of a seat cushion frame, and has two sector gears positioned on left and right sides and connected to each other by a connection bar so that, by strengthening a binding force of the front portion of the seat cushion, it is possible to secure the safety of passengers in the event of a collision.

Abstract: The present disclosure relates to a plurality of host materials comprising a first host material comprising at least one compound represented by formula 1 and a second host material comprising at least one compound represented by formula 2, and an organic electroluminescent device comprising the same. An organic electroluminescent device having significantly improved lifetime properties is provided by comprising a specific combination of compounds according to the present disclosure as host materials.

Abstract: The present disclosure provides a compound of a specific chemical structure or a pharmaceutically acceptable salt thereof, which has the activity of inhibiting and/or degrading mutant EGFR protein. The present disclosure also provides a composition comprising such a compound or a pharmaceutically acceptable salt thereof. The present disclosure provides a pharmaceutical use of a compound according to the present disclosure, a salt thereof, and a composition comprising same for the treatment or prevention of cancer with EGFR mutation, especially lung cancer. The present disclosure also provides a method for treatment or prevention of EGFR mutation cancer, especially lung cancer, the method comprising administering an effective amount of the compound according to the present invention, a salt thereof, or a composition containing same to a subject in need of treatment.

Abstract: A method for performing an assessment related to blood flow in tissue includes receiving fluorescence imaging data associated with movement of a fluorescence imaging agent through a target, determining at least one characteristic associated with a current stage of the movement of the fluorescence imaging agent through the target based on the fluorescence imaging data, comparing the at least one characteristic associated with the current stage to predefined criteria to determine whether the current stage corresponds to a suitable stage for performing an assessment related to blood flow; and, in accordance with the current stage corresponding to the suitable stage, performing the assessment related to blood flow in at least a portion of the target based on the fluorescence imaging data.

Abstract: Provided is a support module for a transmission line sleeve. The support module for the transmission line sleeve includes a plate formed of a flexible material that extends in a longitudinal direction so as to be bent and spread, and a support block coupled along a longitudinal direction of the plate and disposed in plurality adjacently to each other. The support block includes a plurality of lower bodies coupled to the plate at a certain interval, and an upper body coupled to an upper surface of each of the lower bodies so as to form a load supporting portion in which a portion of the upper surface of the lower body is exposed.

Abstract: Provided is a support module for a transmission line sleeve. The support module for the transmission line sleeve includes a plate formed of a flexible material that extends in a longitudinal direction so as to be bent and spread, and a support block coupled along a longitudinal direction of the plate and disposed in plurality adjacently to each other. The support block includes a plurality of lower bodies coupled to the plate at a certain interval, and an upper body coupled to an upper surface of each of the lower bodies so as to form a load supporting portion in which a portion of the upper surface of the lower body is exposed.

Abstract: The present invention relates to a coenzyme Q10 solubilizing composition and a method for preparing the same. In the coenzyme Q10 solubilizing composition and the method for preparing the same according to the present invention, coenzyme Q10, which is a non-soluble drug, is encapsulated by a micelle containing glycyrrhizic acid or a salt of glycyrrhizic acid, bile acid, and unsaturated fatty acid, thereby improving encapsulation efficiency and improving the solubility of coenzyme Q10 in water. In addition, the mass-production of the composition can be easily achieved through sonication or a microfluidizer, the particle size of the composition encapsulating coenzyme Q10 can be controlled, and the natural substance-based formulation without using ethanol and an organic solvent are possible, so that it is expected that the composition of the present invention can be favorably utilized as a composition for pharmaceuticals, foods, and cosmetics, the composition having ensured stability and almost no toxicity.

Abstract: Disclosed herein are compounds, compositions and methods for the treatment of a disease or disorder related to activation of deacetylase enzymes. The compounds and methods are related to boronic acid derivatives of resveratrol. In some forms, the compound, compositions and methods relate to treatment of prostate cancer, colon cancer, or breast cancer, a cardiovascular disease, inflammation, obesity, diabetes, or a neurodegenerative disease.

Abstract: The present invention relates to a coenzyme Q10 solubilizing composition and a method for preparing the same. In the coenzyme Q10 solubilizing composition and the method for preparing the same according to the present invention, coenzyme Q10, which is a non-soluble drug, is encapsulated by a micelle containing glycyrrhizic acid or a salt of glycyrrhizic acid, bile acid, and unsaturated fatty acid, thereby improving encapsulation efficiency and improving the solubility of coenzyme Q10 in water. In addition, the mass-production of the composition can be easily achieved through sonication or a microfluidizer, the particle size of the composition encapsulating coenzyme Q10 can be controlled, and the natural substance-based formulation without using ethanol and an organic solvent are possible, so that it is expected that the composition of the present invention can be favorably utilized as a composition for pharmaceuticals, foods, and cosmetics, the composition having ensured stability and almost no toxicity.

Abstract: The present invention relates to a power duplication apparatus for an HVDC system and a control method therefor, and the power duplication apparatus for an HVDC system comprises: a first independent power generator receiving first input power so as to generate and output first power; a second independent power generator receiving second input power so as to generate and output the first power; a first power supplier selectively receiving the first power output, respectively, from the first independent power generator and the second independent power generator so as to convert the first power into second power having a smaller size than that of the first power and output the same; a second power supplier for selectively receiving the first power output, respectively, from the first independent power generator and the second independent power generator so as to convert the first power into the second power having a smaller size than that of the first power and output the same; a first HVDC controller for receiv

Abstract: The present invention provides a method for operating dual controller which monitors the state of a dual controller to determine whether the dual controller is faulty and enables operation thereof with a controller in a normal state. An operation method of a dual controller according to the present invention dq-converts control command output values of first and second controllers to calculate rates of change in dq conversion values and dq-converts feedback input values, fed back to the first and second controllers, to calculate average rates of change in dq conversion values. When the average rates of change in the dq conversion values for the control command output values and the average rates of change in the dq conversion values for the feedback input values for the respective first and second controllers are identical, the corresponding controller is determined to be in a normal state, and to be in a faulty state otherwise.

Abstract: The present invention relates to a power duplication apparatus for an HVDC system and a control method therefor, and the power duplication apparatus for an HVDC system comprises: a first independent power generator receiving first input power so as to generate and output first power; a second independent power generator receiving second input power so as to generate and output the first power; a first power supplier selectively receiving the first power output, respectively, from the first independent power generator and the second independent power generator so as to convert the first power into second power having a smaller size than that of the first power and output the same; a second power supplier for selectively receiving the first power output, respectively, from the first independent power generator and the second independent power generator so as to convert the first power into the second power having a smaller size than that of the first power and output the same; a first HVDC controller for receiv

Abstract: Disclosed herein are compounds, compositions and methods for the treatment of a disease or disorder related to activation of deacetylase enzymes. The compounds and methods are related to boronic acid derivatives of resveratrol. In some forms, the compound, compositions and methods relate to treatment of prostate cancer, colon cancer, or breast cancer, a cardiovascular disease, inflammation, obesity, diabetes, or a neurodegenerative disease.

Abstract: The present invention relates to a probe for iFRET and use thereof. Specifically, the present invention relates to a novel probe for iFRET, a method for preparing the probe for iFRET, a method for searching a target protein-specific binding site or a molecule having the binding site using the probe for iFRET, and a method for imaging the target protein using the probe for iFRET. The probe for iFRET according to the present invention utilizes an amino acid in a protein as a fluorescent donor, unlike the conventional FRET method. Therefore, only one fluorescent material is used, and its emission wavelength is distinct from the intrinsic fluorescence of the protein. Thus, high specificity and sensitivity are ensured, and the quantity, activity and mechanism of various proteins can be analyzed in an easy and accurate manner.

Abstract: A microscope apparatus for detecting or imaging a target protein using a probe for intrinsic fluorescence resonance energy transfer (iFRET) according to the present invention comprises: a light irradiation unit that irradiates a first light having a wavelength range for exciting an amino acid in the target protein and a second light having a wavelength range for exciting a fluorescent molecule of the probe for iFRET; an objective lens that allows the lights irradiated from the light irradiation unit to be incident onto a sample into which the probe for iFRET is introduced; and a recognition unit that detects a first light emitting signal generated from the probe for iFRET by irradiating the first light having a wavelength range for exciting an amino acid in the target protein onto the sample and a second light emitting signal generated from the probe for iFRET by irradiating the second light having a wavelength range for exciting a fluorescent molecule of the probe for iFRET onto the sample, wherein the probe

Abstract: The present invention relates to a cascade enzyme-linked immunosorbent assay, more precisely a cascade enzyme-linked immunosorbent assay using magnetic microparticles (MMPs) immobilized with the target antigen specific primary antibody and silica nanoparticles (SPs) immobilized with a cascade reaction initiator and the antigen-specific secondary antibody. When the method of the present invention is applied in the detection of an antigen in biosamples, the detection sensitivity can be significantly increased.

Abstract: The present invention relates to a method for preparing an protein monolayer using a peptide hybrid for protein immobilization, more precisely a peptide hybrid for protein immobilization which has improved solubility by introducing a PEG linker and a proper reaction group to the oligopeptide having specific affinity to selected types of proteins and is designed to provide enough space between solid substrates and proteins immobilized, whereby various solid substrates treated by the hybrid catch specific proteins effectively on. The peptide hybrid for protein immobilization of the present invention facilitates the control of orientation of an antibody on various solid surfaces and immobilization of various antibodies of different origins or having different isotypes with different affinity. Therefore, the surface treatment technique using the peptide hybrid of the invention can be effectively used for the production of various immunosensors and immune chips.